Oseltamivir Prescribing in Pharmacy-Benefits Database, United States, 2004–20051
Open Access
- 1 August 2008
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 14 (8) , 1280-1283
- https://doi.org/10.3201/eid1408.080074
Abstract
We reviewed information from a US pharmacy benefits manager database from 2004 through 2005 during periods with little influenza activity. We calculated rates of oseltamivir prescriptions to enrollees. Prescription rates increased significantly from 27.3/100,000 in 2004 to 134/100,000 in 2005 (p<0.05), which suggested that personal stockpiling of oseltamivir occurred.Keywords
This publication has 7 references indexed in Scilit:
- A National Survey of the Infectious Diseases Society of America Emerging Infections Network concerning Neuraminidase Inhibitor Prescription Practices and Pandemic Influenza PreparationsClinical Infectious Diseases, 2006
- Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).2006
- Update: influenza activity--United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine.2006
- Increased antiviral medication sales before the 2005-06 influenza season--New York City.2006
- The Run on Tamiflu — Should Physicians Prescribe on Demand?New England Journal of Medicine, 2005
- Update: Influenza activity--United States and worldwide, 2004-05 season.2005
- Development of a Chronic Disease Indicator Score Using a Veterans Affairs Medical Center Medication DatabaseJournal of Clinical Epidemiology, 1999